Monsanto shares (NYSE: MON) were up less than 1 percent as of Wednesday morning, to $88.08 per share.
Advertisement
In the report, Monsanto revealed that their sales from 2015’s fiscal year were driven by the company’s Seeds and Genomics Segment, but were offset by foreign currency issues, declining corn acres, and lower herbicide prices.
Successive many years of huge jot harvesting festivals in north america have thought out seriously on speck rates and windswept grower salaries, and has changed on Monsanto’s sprout income. Four analysts surveyed by Zacks expected $2.89 billion.
The company said it would still meet its target of more than doubling fiscal 2014 earnings per share, excluding special items, by 2019.
The St. Louis-based company then said that it is hoping for the job cuts to to help generate an amount between $275 million and $300 million by the end of the 2017 fiscal year.
Monsanto also announced a new 3 billion accelerated share buyback program, after completing a 6 billion repurchase program in 2015.
Analysts projected a loss of 2 cents a share on sales of $2.77 billion, according to Thomson Reuters. And sales at the company’s agricultural productivity unit, which includes Roundup herbicide, dropped to $1.1bn from $1.25bn in the quarter.
Monsanto expects full-year earnings in the range of $5.10 to $5.60 per share. The increase follows Monsanto’s acquisition in 2013 of the Climate Corp. for $930 million, offering farmers novel options in the way they manage risk, including the biggest risk, weather.
Seed companies such as Monsanto, alongside suppliers of fertilizer and farm machinery, face a third straight year of sagging prices for corn, soybeans and wheat that have forced belt-tightening across major agricultural regions.
A combination with Basel-based Syngenta would have made Monsanto the world’s largest producer of farming chemicals, in addition to its existing market-leading biotech seed business. But the Swiss pesticide maker rejected a series of unsolicited offers from the American company.
Shares of Monsanto were down 1.5 percent at $86.22 in early trading.
Advertisement
At Tuesday’s close, the stock had dropped roughly 30 percent from a high set last February, and the company’s growth strategy has under intense investor scrutiny after the failed Syngenta takeover attempt.
